InfaCare Pharmaceuticals Corporation Report issue

For profit Phase 2 Phase 3
Founded: Feasterville Trevose PA United States (2005)
Status: Acquired by Mallinckrodt (2013) (2017)

Organization Overview

First Clinical Trial
2005
NCT02685137
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (1)

tin-mesoporphyrin (7 trials)

Drugs in Phase 2 Trials (1)

sodium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperbilirubinemia (Phase 2)

Hyperbilirubinemia, Neonatal (Phase 2)

Jaundice (Phase 2)

Jaundice, Neonatal (Phase 2)

Metabolic Diseases (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 7
  • # of Trial APIs: 2